awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34134900-AE4118E4-3E77-4242-B70C-7E1545A7C3AE
Q34134900-AE4118E4-3E77-4242-B70C-7E1545A7C3AE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34134900-AE4118E4-3E77-4242-B70C-7E1545A7C3AE
48-week efficacy and safety of dolutegravir relative to commonly used third agents in treatment-naive HIV-1-infected patients: a systematic review and network meta-analysis.
P2860
Q34134900-AE4118E4-3E77-4242-B70C-7E1545A7C3AE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34134900-AE4118E4-3E77-4242-B70C-7E1545A7C3AE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2566c6550f9147918b3434b208dc96592424b33d
P2860
Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT.